Article Information
History
- July 9, 2020.
Article Versions
- Version 1 (June 17, 2020 - 23:33).
- Version 2 (June 30, 2020 - 22:16).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Stephen Tang1,2,
- Nebiyou Y. Metaferia1,
- Marina F. Nogueira1,2,
- Maya K. Gelbard1,
- Sarah Abou Alaiwi1,3,
- Ji-Heui Seo1,3,
- Justin H. Hwang1,2,
- Craig A. Strathdee2,
- Sylvan C. Baca1,2,3,
- Jiao Li1,
- Shatha AbuHammad1,
- Xiaoyang Zhang4,
- John G. Doench2,
- William C. Hahn1,2,5,
- David Y. Takeda6,
- Matthew L. Freedman1,2,3,5,
- Peter S. Choi7,8,* and
- Srinivas R. Viswanathan1,2,5,*
- 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA
- 2Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
- 3Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA
- 4Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA
- 5Harvard Medical School, Boston, MA 02215, USA
- 6Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
- 7Division of Cancer Pathobiology, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA
- 8Department of Pathology & Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA
- ↵*Correspondence:
peter.choi{at}pennmedicine.upenn.edu (P.S.C.), srinivas.viswanathan{at}dfci.harvard.edu (S.R.V.)